Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. |
| |
| Authors: | Charles H Adler Stewart A Factor Mitchell Brin Kapil D Sethi |
| |
| Affiliation: | Parkinson's Disease and Movement Disorders Center, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA. cadler@mayo.edu |
| |
| Abstract: | ![]()
Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period. |
| |
| Keywords: | oromandibular dystonia botulinum toxin immunoresistance |
|
